Cumberland Pharmaceuticals Mergers and Acquisitions Summary

Life ScienceCompany

Cumberland Pharmaceuticals has acquired 1 company, including 1 in the last 5 years.

Cumberland Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired Theravance Biopharma - VIBATIV for $20M. Cumberland Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Cumberland Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals, Inc.

1600 West End Avenue,
Nashville, Tennessee 37203
United States,
(615) 255-0068

Cumberland Pharmaceuticals is a pharmaceutical company. Cumberland Pharmaceuticals acquires and develops branded prescription products primarily in the gastroenterology, critical care and infection control areas. Cumberland Pharmaceuticals was founded in 1999 and is based in Nashville, Tennessee.

M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (0.0/yr) # 1 - - - - - 1
vol $20M $20M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Theravance Biopharma, Inc. - VIBATIV 2018-11-06 20M USD Divestiture
South San Francisco, California ·
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 20M (100%) - -
Total 1 $20M - -

By Geo

State/Country Buy Value Sell Value
United States 1 20M - -
  California 1 20M - -
Total 1 $20M - -

Deal Values

buy # Total
< $100M 1 $20M
Largest Theravance Biopharma, Inc. - VIBATIV
$20M (2018-11-06)

M&A Connections

Acquired from
1 (100%)

 Subscribe to unlock this and 191,259
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.4K Private Equity Firms
  • 182K M&A Transactions
  • 187K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 69K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.